We welcome Koji Hasegawa (Japan) as President of ISCP for 2018 and Augusto Gallino (Switzerland) as Vice-President and President Elect. Prof Hasegawa is also the chairperson for the Host Organising Committee for the 23rd ISCP Annual Scientific Meeting, which is being held on the 26th and 27th of May, 2018 at the Ritz-Carlton in Kyoto. The meeting’s website is now active and includes information in English and Japanese on registration and abstract submission as well as information on Best Abstract Awards and Overseas Travel Grants.
Please note that a Board of Directors Meeting has been scheduled for Friday 25th of May at 17:30 during the Annual Scientific Meeting, and a Governors and General Assembly meeting will be held on Sunday 27th of May at 10:30.
The Executive Committee and Board of Directors has also commenced planning for the 2019 ISCP Annual Scientific Meeting. This meeting will be held in Lugano, Switzerland.
Remember that Full and Junior members can now access regularly updated Expert Reviews and Expert Opinions on the website as well as Webinars and Conference Talks. See below for information on how to sign up if you’re not already a member.
Please forward any news or information on upcoming conferences or meetings that you would like included in the next Newsletter (June 2018) to me at firstname.lastname@example.org by the 24th of May 2018.
Editors: John McNeil & Lisa Demos
It is a great pleasure and honour to welcome you to the 23rd Annual Scientific Meeting of the International Society of Cardiovascular Pharmacotherapy (ISCP), which is scheduled for May 26th–27th, 2018, at the Ritz-Carlton, Kyoto, Japan. We invite you to join us for scientific exchange on current topics in evidence-based clinical management and eagerly look forward to your active participation in the 2018 Kyoto ISCP meeting. We are certain that you will enjoy the most up-to-date scientific program, entertaining social and cultural events, and the unique atmosphere of historic Kyoto.
Registration and Call for Abstract sites are now open. Please visit ISCP2018.com
Prof Koji Hasegawa,
Chair, 23rd Annual Scientific Meeting of ISCP
Information on the upcoming Annual Scientific Meeting is available on www.iscp2018.com. Sessions include:
- Future Pharmacotherapy for Atherosclerosis:
- Basic Science for the Clinician;
- Cardiac and Systemic Linkage for the Control of Hypertension;
- Pulmonary Hypertension;
- Prevention of Atherosclerotic Events by Targeting Lipid Metabolism and Inflammation;
- Global Cardiovascular Risk Management to Achieve ‘25 by 25’;
- Reprograming and Regeneration of the Heart: Basic Science for the Clinician;
- Recent Advances in Cardiomyopathies,
- Myocarditis and Heart Failure;
- Up-to-date Topics of Atrial Fibrillation and Anti-coagulant Therapy;
- Pharmacotherapy and Life-style Modification for Heart Failure: the Present and the Future;
- Cardiovascular Imaging Guiding Pharmacotherapy;
- Controversies in Anti-coagulant Therapy in Atrial Fibrillation and Deep Vein Thrombosis;
- Treatment of Atrial Fibrillation: the Place of Antiarrhythmic Drugs;
- Prediction and Prevention of Sudden Cardiac Death and Syncope;
- Drug Management of Coronary Vasospasm, Microvascular Angina and Takotsubo Cardiomyopathy;
- Biomarkers to Predict Acute Coronary Syndrome and Heart Failure;
- Anti-thrombotic Therapy during and after Coronary Intervention
The Henry N. Neufeld Memorial Award Lecture will be given by Prof Lina Badimon from the Catalan Institute of Cardiovascular Sciences (ICCC), the Spanish National Research Council (CSIC) and CIBERCV, Carlos III Institute in Spain. The title of her talk is Precision Medicine: Molecular Phenotyping in Cardiovascular Pharmacotherapy.
The call for abstracts is open and the deadline for abstract submission is the 17th of April 2018. English is the official language of the Congress and abstracts must be submitted in English.
An Early Registration rate is available until the 17th of April 2018.
Gheorghe-Andrei Dan was the Chair of the Task Force that recently published an EHRA Position Paper on antiarrhythmic drugs and Antoni Martinez-Rubio was the co-Chair. Other ISCP members on the Task Force included Juan Carlos Kaski, Tatjana Potpara, Magdi Saba and Juan L. Tamargo, whilst Felipe Martinez was one of the reviewers. This is the first European guideline made in cooperation with ISCP and the first antiarrhythmic position paper after more than 10 years.
Dan G-A, Martinez-Rubio A, Agewall S et al. Antiarrhythmic drugs–clinical use and clinical decision-making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP). Europace 2018; 1–42, doi:10.1093/europace/eux373.
A joint ISCP – French Society of Cardiology symposium took place during the 28th European Days of the French Society of Cardiology. The Congress was held at the Palais des Congrès in Paris on the 17th-20th of January 2018.
Thursday 18th of January included a Joint session titled The Yin and Yang of Molecular Cardiac Mechanisms. The Chairpersons were Theodora Bejan-Angoulvant and Jean-Sébastien Hulot. The session included the following presentations:
- Dennis Cokkinos speaking on “Preconditioning: Protecting with Ischemia”
- Michel Ovize speaking on “The Reperfusion Injury: Is it Treatable?”
- Geneviève Derumeaux speaking on “Myocardial Hypertrophy: When is it Good and When is it Bad?”
- Gheorghe-Andrei Dan speaking on “Drug Treatment of Arrhythmias”
The Congress had a high attendance rate and the symposium was of a high scientific level. Each presentation was followed by numerous discussions.
Edgardo Escobar presented the Opening Lecture From Basic and Clinical Research to the Digital Era at the Chilean Congress of Cardiology on the 30th of November 2017.
Prof Escobar is a member of the Board of Directors of the ISCP.
The 21st Annual Scientific Meeting of the Institute of Cardiovascular Science and Medicine was held on 11th of November 2017 at the Hong Kong Convention and Exhibition Centre. The meeting brought together clinicians and scientists in order to promote cooperation and interaction in research.
Invited speakers addressed a diverse range of topics, from mechanosensitive TRP channels in the cardiovascular system to the management of stable chronic heart failure in a primary care setting, while young researchers competed for the Sun Chieh Yeh Heart Foundation Young Investigators Award.
Membership payments were due by 31st of January 2018. If payment is not received by the 31st of March 2018 membership will be changed to Web membership (which is free but provides only limited benefits). Full membership is €90.00 whilst junior members who provide proof of status are entitled to free membership.
Member benefits include the ISCP newsletter, unrestricted access to all areas of ISCP website, including Experts and e-Learning sections, and electronic access to European Cardiology Review.
To join the ISCP or renew your membership go to: https://www.iscpcardio.org/register/
The Current Cardiovascular Therapy Series is created with the support of the ISCP. The books provide both an in-depth view of the science and pharmacology behind these drugs and a practical guide to their usage. Each volume is designed to be between 120 and 250 pages, containing practical illustrations and designed to improve understanding and practical usage of cardiovascular drugs in specific clinical areas.
The series currently includes 9 books: Antiplatelet and Anticoagulation Therapy; Pharmacological Treatment of Acute Coronary Syndromes; Atrial Fibrillation Therapy; Cardiac Drugs in Pregnancy; Pharmacotherapy in Aortic Disease; Pharmacologic Trends of Heart Failure; Pharmacological Treatment of Chronic Stable Angina Pectoris; ACEi and ARBS in Hypertension and Heart Failure; Treatment of Pulmonary Hypertension.
The books are available as e-books or in soft cover at a discounted rate for ISCP members.
The European Cardiology Review is a peer-reviewed bi-annual journal comprising review articles, editorials and case reports. The journal is led by Editor-in-Chief Juan Carlos Kaski, supported by Associate Editors, and underpinned by an editorial board of world-renowned physicians.
The latest edition. Volume 2, 2017, was released in December 2017 and is accessible to all members via the ECR website. This edition includes the 20 best abstracts from the last ISCP Scientific Meeting in Barcelona.
For information on submitting an article, please contact the Managing Editor, Lindsey Mathews: email@example.com
Official Relations Status with WHO: Following a review in January, the World Heart Federation’s Official Relations status with the World Health Organization (WHO) was renewed during the 142nd session of the WHO Executive Board. Items on the WHO Executive Board agenda included: the adaptation of the Draft Thirteenth General Programme of Work and Global Action Plan on Physical Activity for 2018-2030; the global shortage of, and access to, medicines and vaccines; and the UN High-level Meeting on NCDs in 2018.
Global Coalition for Circulatory Health: WHF invites any professional global, regional, and national civil society organizations with a role in circulatory health to register their interest in joining the Global Coalition for Circulatory Health. The Coalition unites international, regional and national stakeholders in CVD to drive the urgent action needed to combat heart disease and stroke, in preparation for the third UN High-level Meeting on NCDs in 2018.
#QuitBigTobacco initiative: WHF pledges not to work with agencies that work with Big Tobacco, and encourages members to do the same.
WHF Roadmaps: These provide a general framework for regions and countries to identify barriers to reducing premature CVD mortality, and offer evidence-based solutions to overcome these barriers through policy and health systems strategies. A number of Roadmaps on different cardiovascular topics have been published and two more will soon be published on Heart Failure and Diabetes.
WCC 2018: The World Congress on Cardiology and Cardiovascular Health will be held in Dubai from 5th-8th of December 2018. WHF Vice President-Elect, Dr Nooshin Bazargani, elaborates on how WCC 2018 will merge science, advocacy and prevention on a global scale.
Abstract submissions for WCC 2018 are open and the submission deadline is 11th of April 2018. Online registration opens on 2nd of April 2018 and the early registration deadline is 17th of July 2018.
The 3rd Global Summit on Circulatory Health will be on 4th-5th of December 2018, just before the WCC.
Starting in 2019 WHF will be moving to a new annual World Congress model, which will align all future congresses with members’ congresses and events.
Acute Cardiovascular Care 2018
3 – 5 March, 2018
ACC 2018 – 67th Annual Scientific Session & Expo
10 – 12 March 2018
18 – 20 March, 2018
19 – 21 April, 2018
65th Annual Conference of the Israel Heart Society
24 – 25 April 2018
Tel Aviv, Israel
52nd AECP Annual Meeting
9 – 12 May 2018
EuroCVP 2018 Congress
13 – 14 May 2018
Tel Aviv, Israel
ISCP Annual Scientific Meeting 2018
26 – 27 May, 2018
Heart Failure 2018
26 – 29 May, 2018
Asia Pacific Society of Cardiology Congress
17 – 20 May 2018
5 – 8 June 2018
7 – 9 June, 2018
ESC Congress 2018
25 – 29 August 2018
23rd ASEAN Federation of Cardiology Congress
28 September – 1 October 2018
5 – 8 December, 2018